Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8
|
pubmed:dateCreated |
1991-10-4
|
pubmed:abstractText |
The subcellular distribution of the c-abl and bcr-abl gene products from KG1A and K562 cells has been studied by two different techniques. Firstly, physical disruption followed by subcellular fractionation was used to demonstrate that normal c-abl (p145) was recovered from the cytosol and the nuclear fractions of KG1A cells. In contrast, bcr-abl products were recovered exclusively from the cytosol fraction of K562 cells. Secondly, indirect immunofluorescence was used to localize c-abl protein to the cytoplasm, nuclear membrane and infrequently to the nucleus of KG1A cells and bcr-abl protein to only the cytoplasm of K562 cells. Thus both the approaches indicate that there is a component of normal c-abl products which appears to be nuclear and this is not reflected in the distribution of the bcr-abl 210 kDa protein, which remains cytosolic.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0950-9232
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
6
|
pubmed:geneSymbol |
c-abl
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1459-64
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:1886716-Animals,
pubmed-meshheading:1886716-Cell Fractionation,
pubmed-meshheading:1886716-Cell Line,
pubmed-meshheading:1886716-Cell Nucleus,
pubmed-meshheading:1886716-Cytosol,
pubmed-meshheading:1886716-Fluorescent Antibody Technique,
pubmed-meshheading:1886716-Fusion Proteins, bcr-abl,
pubmed-meshheading:1886716-Gene Expression,
pubmed-meshheading:1886716-Humans,
pubmed-meshheading:1886716-Precipitin Tests,
pubmed-meshheading:1886716-Proto-Oncogene Proteins c-abl,
pubmed-meshheading:1886716-Tumor Cells, Cultured
|
pubmed:year |
1991
|
pubmed:articleTitle |
Normal c-abl gene protein--a nuclear component.
|
pubmed:affiliation |
Medical Oncology Laboratory, Imperial Cancer Research Fund, St Bartholomew's Hospital, London, UK.
|
pubmed:publicationType |
Journal Article
|